title: OKT3 induction in 100 consecutive pancreas transplants.
authors.affiliation: Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280.
authors.forename: R J
authors.initials: RJ
authors.lastname: Stratta
authors.forename: R J
authors.initials: RJ
authors.lastname: Taylor
authors.forename: J A
authors.initials: JA
authors.lastname: Lowell
authors.forename: J S
authors.initials: JS
authors.lastname: Bynon
authors.forename: M S
authors.initials: MS
authors.lastname: Cattral
authors.forename: K
authors.initials: K
authors.lastname: Frisbie
authors.forename: S
authors.initials: S
authors.lastname: Miller
authors.forename: D C
authors.initials: DC
authors.lastname: Brennan
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3